Please ask the national audit non-invasive blood glucose meter really listed?

According to the latest results, the 625MARD value of CAS non-invasive glucose monitoring technology has reached 13.42%, which has met the national standard for listing of glucose monitoring devices.

Non-invasive glucose monitoring technology has many advantages, such as non-invasive, convenient, painless, etc., but its accuracy problem has always been a challenge, and the listing of non-invasive glucose meters needs further technical breakthroughs and market validation.

In addition to this, the accuracy issue has been a challenge, and the launch of non-invasive blood glucose meters needs further technical breakthroughs and market validation.

In addition, it is worth mentioning that on August 26, 2019, the high-tech product "non-invasive blood glucose meter", which was researched and developed by Bo Bang Fang Zhou Medical Technology (Beijing) Co., Ltd. and Tsinghua University after ten years of cooperation, has obtained the certificate of registration of Class III medical device issued by the State Drug Administration. In general, the age of non-invasive blood glucose meter on the market has taken an important step forward, but in the technology and the market is still facing some challenges, the need for continued research and development and market testing. So it's not on the market.